cancer treatment

Stories 61 - 80 | << Prev   Next >>

Promising 'Trojan Horse' Cells Kills Animal Cancer

Sydney biotech firm to begin human trials in coming months

(Newser) - Australian researchers have achieved promising results with a new approach to treating cancer, reports the Sydney Morning Herald. Scientists have developed mutant bacteria nanocells that slip into tumor cells to switch off drug-resistant genes, and allow cancer-fighting drugs inside, also delivered by the nanocells. The strategy has achieved near-universal success...

New Class of Drugs Could Revolutionize Cancer Treatment

PARP inhibitors show potential to transform understanding of cancer

(Newser) - A new class of drugs in development represents the biggest cancer breakthrough in a decade, Robert Bazell writes at NBC. In a study causing much excitement in the medical world, breast, ovarian, and prostate cancer patients treated with Olaparib, one of a group of drugs known as PARP inhibitors, had...

VA Doc Botched 92 of 116 Cancer Operations

Philly prostate patients routinely had treatment placed in wrong organ

(Newser) - The VA Hospital in Philadelphia performed 116 operations to treat prostate cancer before an investigation found that 92 of the them had been seriously botched, the New York Times reports. The VA considered Dr. Gary Kao an expert who didn't need oversight, and allowed him to cover up his mistakes...

New Prostate Cancer Drug Amazes Researchers

Experimental therapy cures men's inoperable cancer

(Newser) - The total recovery of two patients suffering inoperable prostate cancer under a new treatment has amazed researchers at the Mayo Clinic, the Minnesota Post reports. The men, who suffered from a highly aggressive and deadly form of the disease, were found to be cancer-free after treatment with an experimental drug...

Poor Harry Still Pines for Chelsy
 Poor Harry Still Pines for Chelsy 
GOSSIP ROUNDUP
Jun 15, 2009 1:05 PM CDT

Poor Harry Still Pines for Chelsy

Plus, Susan Boyle rejoins tour, and more

(Newser) - Prince Harry split with his latest galpal, British TV host Caroline Flack, when he realized ex Chelsy Davy was “the best thing that has ever happened to me,” he told friends. “The fling with Caroline has focused Harry’s mind back on Chelsy,” one tells the...

Cure Still Elusive as Cancer Treatments Improve

(Newser) - The world’s largest cancer conference convened this weekend and offered some hope but no cures, USA Today reports. Researchers are getting closer to developing treatments that are gentler and more individualized, and that increase longevity and quality of life. But a cure remains elusive, and even the most promising...

Fawcett's Treatment Has Ended; Golden Locks Gone

(Newser) - Farrah Fawcett’s treatment for anal cancer “has pretty much ended,” partner Ryan O’Neal tells People. The 62-year-old actress spends nearly all of her time in bed now, with doctors trying to make her as comfortable as possible. “I just don't know how to play this...

Colon Cancer Drug Flunks Important Test

Avastin's effects on early-stage disease don't meet expectations

(Newser) - Clinical trials to determine the drug Avastin’s effects on early-stage colon cancer were a big disappointment for drug firm Genentech, the New York Times reports. The drug, which is typically used in late-stage cancer, didn’t significantly cut the recurrence rate among 2,700 subjects in the early stages,...

Cancer Spreads, But Fawcett Not at Death's Door: Sources

(Newser) - Farrah Fawcett’s anal cancer spread to her liver in 2007, indicating that the malady is worse than previously thought, the AP reports. Her ongoing stay at a Los Angeles hospital is the result of treatment she underwent in Germany, but not directly related to her cancer, her doctor said....

Swayze Fires Back at 'Negative' Tabloids

Actors slams reports that he's losing cancer fight

(Newser) - Patrick Swayze is sick of reading tabloid stories claiming he's losing his battle with pancreatic cancer, he tells Access Hollywood. The Beast star says that rather than being at death's door, he is responding well to a new course of chemotherapy, and he has plenty of positive things in his...

Cancer Study Unlocks Clues to Who Lives, Who Dies

Breakthrough helps docs decide treatment

(Newser) - A new discovery may help predict whether a woman with breast cancer is more likely to live or die, reports Reuters. The breakthrough may help doctors make vital decisions about which patients should be treated the most aggressively. Researchers discovered patients were more likely to survive the disease if they...

Swayze: I Haven't Quit Treatment

(Newser) - Patrick Swayze quickly scotched tabloid rumors today that he's stopped receiving treatments for his pancreatic cancer, People reports. "The reports are not true," said a spokeswoman. "Patrick is continuing his treatment." Swayze, 56, was hospitalized earlier this month for pneumonia, and several tabloids reported that he'd...

Study May Help Mastectomy Dilemma

Research identifies factors likely to imperil second breast

(Newser) - Researchers alarmed by a spike in potentially unnecessary double mastectomies have identified three risk factors that might help breast cancer patients make better decisions about whether to have a healthy breast removed, the Houston Chronicle reports. The research was motivated by an earlier study that revealed 80% of women who...

Jack Kemp Treated for Cancer
 Jack Kemp Treated for Cancer 
Jan 7, 2009 1:34 PM CST

Jack Kemp Treated for Cancer

Docs can't say what afflicts former NFL star, GOP lawmaker, 73

(Newser) - Jack Kemp, the former NFL star and Republican congressman, is in treatment for cancer, the Buffalo News reports. A spokeswoman said the type of cancer is “undetermined,” but that tests are under way to identify it. Kemp, 73, served 18 years as a representative from New York before...

Gene Discovery Raises Breast Cancer Hopes

Targeted therapy may prevent lethal spread, researchers say

(Newser) - Researchers have singled out a gene that spreads breast cancer and makes it chemo-resistant, raising the prospect of drug therapy that localizes the disease and improves survival rates, the Baltimore Sun reports. Scientists believe that metadherin, or MTDH—found in 40% of the breast cancer patients studied—makes tumor cells...

Money or Your Life? Brits Weigh Drug Cost Vs. Benefit

With its restrictions forcing companies to lower prices, some see 'workable paradigm' for US

(Newser) - A British government institute that approves drugs based on cost-benefit analysis is coming under fire at home even as other countries are seeing it as a model for bringing down costs, the New York Times reports. Though the National Institute for Health and Clinical Excellence often balks at expensive life-prolonging...

Doctors Fight to Beat Cultural Cancer Taboos

Stigma surrounding cancer suspected of causing higher mortality rates

(Newser) - The fight against cancer is being hindered by the stigma the illness carries in many cultures, the Wall Street Journal reports. Chinese, Russians, Muslims, and many other groups may shun treatment and try to keep their condition secret. Experts believe the taboo plays a big role in the higher cancer...

Quicker Therapy Just as Good for Breast Cancer

Intensive radiation for 3 weeks or less works well in 12-year study

(Newser) - Intensive, short-term radiation therapy battles breast cancer as well as the usual longer treatment, Canadian researchers said today. Their study of 1,200 women showed that after 12 years, 1 to 3 weeks of daily treatment kept cancer at bay slightly better than 5 to 7 weeks of the more...

Behind Kennedy Tumor Surgery: Rally of Top Experts

Senator is able to summon leading experts to advise on his case

(Newser) - After his brain cancer diagnosis, Ted Kennedy wielded extraordinary clout to convene a  panel of more than a dozen top experts from around the country for a conference—with some doctors flying to Boston and some on the phone—that changed the course of his treatment. Kennedy opted for surgery...

Popular Cancer Drug Is Iffy and Expensive

Widely prescribed Avastin doesn't prolong life, studies say

(Newser) - Avastin is one of the most widely prescribed cancer drugs in the world, but it might not work, the New York Times reports. The drug, made by Genentech, brings in about $2.3 billion a year in the US alone, but recent trials have shown that though the drug shrinks...

Stories 61 - 80 | << Prev   Next >>
Most Read on Newser